Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome

Kenneth Ssebambulidde; Seher H. Anjum; Jessica C. Hargarten; Prashant Chittiboina; Shmuel Shoham; Seyedmojtaba Seyedmousavi; Kieren A. Marr; Dima A. Hammoud; Bridgette Jeanne Billioux; Peter R. Williamson

doi:10.3389/fneur.2022.994396

Frontiers in Neurology (Dec 2022)

Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome

Kenneth Ssebambulidde,
Seher H. Anjum,
Jessica C. Hargarten,
Prashant Chittiboina,
Shmuel Shoham,
Seyedmojtaba Seyedmousavi,
Kieren A. Marr,
Dima A. Hammoud,
Bridgette Jeanne Billioux,
Peter R. Williamson

Affiliations

Kenneth Ssebambulidde: Translational Mycology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
Seher H. Anjum: Translational Mycology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
Jessica C. Hargarten: Translational Mycology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
Prashant Chittiboina: Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States
Shmuel Shoham: Johns Hopkins School of Medicine, Baltimore, MD, United States
Seyedmojtaba Seyedmousavi: Microbiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States
Kieren A. Marr: Johns Hopkins School of Medicine, Baltimore, MD, United States
Dima A. Hammoud: Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, United States
Bridgette Jeanne Billioux: Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States
Peter R. Williamson: Translational Mycology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

DOI: https://doi.org/10.3389/fneur.2022.994396
Journal volume & issue: Vol. 13

Abstract

Read online

Cryptococcal meningoencephalitis (CM) continues to cause major morbidity and mortality in a range of patients such as those immunosuppressed from HIV and with biologic immunosuppressants, including treatments of autoimmunity, malignancies, and conditioning regimens for transplantation. It is currently the most common cause of non-viral meningitis in the United States. Infections in previously healthy patients also develop with autoantibodies to granulocyte-macrophage colony stimulating factor or with monogenetic defects. In all populations, mortality and significant long-term morbidity occur in 30–50% despite therapy, and immune reconstitution and post-infectious inflammatory response syndromes complicate management. To help with these difficult cases, we present here a practical tutorial of the care of a range of patients with CM in the absence of HIV/AIDS.

Published in Frontiers in Neurology

ISSN: 1664-2295 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://www.frontiersin.org/journals/neurology/

About the journal

Abstract

Keywords